Hanover Insurance Group, Inc. (THG) Executive Vice President Bryan J. Salvatore reported an acquisition of 24 shares of common stock on September 25, 2026, through a grant of restricted stock units under the 2022 Long-Term Incentive Plan. The grant arose from accrued dividend equivalent rights associated with previously granted RSUs. Salvatore's reported direct common-stock holdings after the transaction were 29,118 shares.
The Hanover Insurance Group, Inc. reported that its President and CEO, John C. Roche, received a grant of 120 restricted stock units on September 25, 2026. The grant was made under the company’s 2022 Long-Term Incentive Plan in connection with dividend equivalent rights on previously granted RSUs; these RSUs vest on the third anniversary of the original underlying RSUs’ grant date. Roche’s reported direct common-stock holdings after the grant were 141,253 shares, excluding 14,454 shares held by his spouse.
The Hanover Insurance Group, Inc. (THG) reported that Patricia A. Norton-Gatto, SVP and Principal Accounting Officer, received approximately 6 restricted stock units on September 25, 2026. The award was made under the 2022 Long-Term Incentive Plan in connection with dividend equivalent rights on previously granted RSUs. Her reported direct Common Stock holdings after the transaction were approximately 2,452 shares.
The Hanover Insurance Group, Inc. (THG) Executive Vice President David John Lovely acquired 10 shares of common stock on September 25, 2026, through a restricted stock unit award tied to dividend equivalent rights on previously granted units. His reported direct common-stock holdings following the award were 3,829 shares.
Hanover Insurance Group, Inc. Executive Vice President Willard T. Lee received a grant of 10.64 restricted stock units (RSUs) on September 25, 2026. The award relates to accrued dividend equivalent rights on previously granted RSUs under the company's 2022 Long-Term Incentive Plan. The reported direct common-stock position following the award was 6,004 shares.
The Hanover Insurance Group, Inc. (THG) reported a grant of 28 restricted stock units to Executive Vice President Richard W. Lavey on September 25, 2026. The grant was made under the 2022 Long-Term Incentive Plan in connection with dividend equivalent rights on previously granted RSUs. The units vest on the third anniversary of the grant date of the original underlying RSUs; Lavey’s reported direct holdings after the transaction were 34,475 shares.
Hanover Insurance Group, Inc. (THG) Executive Vice President Dennis Francis Kerrigan received 15 restricted stock units on September 25, 2026, in a direct award tied to dividend equivalent rights on previously granted RSUs. The award is under the company’s 2022 Long-Term Incentive Plan, and the awarded RSUs vest on the third anniversary of the original underlying RSUs’ grant date. Kerrigan’s reported direct common-stock holdings after the transaction were 12,018 shares.
Hanover Insurance Group, Inc. (THG) Executive Vice President Jeffrey M. Farber acquired 42 common shares on September 25, 2026, through a grant of restricted stock units under the company’s 2022 Long-Term Incentive Plan. The grant relates to dividend equivalent rights on previously granted RSUs; these RSUs vest on the third anniversary of the original underlying RSUs’ grant date. Farber directly held 68,819 shares after the transaction.
HANOVER INSURANCE GROUP, INC. (THG) received a Rule 144 notice for a proposed sale of its common stock by Denise M. Lowsley. The notice covers 9,864 shares to be sold through Fidelity Brokerage Services LLC, with an aggregate market value of $2,280,314.62, versus 34,820,221 shares outstanding. The shares were acquired via a stock option exercise on September 16, 2026, for cash.
HANOVER INSURANCE GROUP, INC. (THG) reported insider equity transactions by Executive Vice President Dennis Francis Kerrigan. On August 19–20, 2026, he exercised options to acquire a total of 8,655 shares of THG common stock at an exercise price of $118.54 per share, from an option that vested in three equal installments on February 28, 2021, 2022 and 2023. The 8,655 shares acquired upon exercise were then sold in open-market transactions on those dates at weighted-average prices around $220–$223 per share under a pre-established Rule 10b5-1 Trading Plan adopted on May 21, 2026.